Treatment of a laboratory-acquired sabiá virus infection

Michele Barry, Mark Russi, Lori Armstrong, David Geller, Robert Tesh, Louise Dembry, Jean Paul Gonzalez, Ali S. Khan, Clarence J. Peters

Research output: Contribution to journalArticle

78 Scopus citations

Abstract

Arenaviruses are a group of RNA viruses several of which have the potential to cause a deadly syndrome of hemorrhagic fever. In humans these viruses are usually transmitted by exposure to infected rodent excreta; occasional laboratory or nosocomial infections have been reported.1 Sabiá virus is an arenavirus that was first isolated in São Paulo, Brazil, in 1990 from an agricultural engineer who presented with a hemorrhagic fever syndrome and ultimately died. Necrosis of the liver was found at autopsy. The virus was subsequently characterized as a new member of the Tacaribe complex of the family Arenaviridae.2 A laboratory technician in.

Original languageEnglish (US)
Pages (from-to)294-296
Number of pages3
JournalNew England Journal of Medicine
Volume333
Issue number5
DOIs
StatePublished - Aug 3 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of a laboratory-acquired sabiá virus infection'. Together they form a unique fingerprint.

  • Cite this

    Barry, M., Russi, M., Armstrong, L., Geller, D., Tesh, R., Dembry, L., Gonzalez, J. P., Khan, A. S., & Peters, C. J. (1995). Treatment of a laboratory-acquired sabiá virus infection. New England Journal of Medicine, 333(5), 294-296. https://doi.org/10.1056/NEJM199508033330505